Objective-To investigate whether and how the endoplasmic reticulum (ER) stress-induced, CCAAT/enhancer-binding protein-homologous protein (CHOP)-mediated pathway regulates myocardial ischemia/reperfusion injury. Methods and Results-Wild-type and chop-deficient mice underwent 50 minutes of left coronary artery occlusion followed by reperfusion. Expression of chop and spliced x-box binding protein-1 (sxbp1) mRNA was rapidly and significantly increased in reperfused myocardium of wild-type mice. chop-deficient mice exhibited markedly reduced injury size after reperfusion compared with wild-type mice, accompanied by a decreasing number of terminal deoxynucleotidyl transferase dUTP nick-end labeling-positive cardiomyocytes. Interestingly, myocardial inflammation, as assessed by expression of inflammatory cytokines and chemokines and numbers of infiltrated inflammatory cells, was also attenuated in chop-deficient mice. Moreover, expression of interleukin-6 mRNA in response to lipopolysaccharide was enhanced by simultaneous stimulation with thapsigargin, a potent ER stressor, in wild-type cardiomyocytes but not in chop-deficient cardiomyocytes. Finally, we found that superoxide was produced in reperfused myocardium and that intravenous administration of edaravone, a free radical scavenger, immediately before reperfusion significantly suppressed the superoxide overproduction and subsequent expression of sxbp1 and chop mRNA, followed by reduced injury size in wild-type mice. Conclusion-The ER stress-induced, CHOP-mediated pathway, which is activated in part by superoxide overproduction after reperfusion, exacerbates myocardial ischemia/reperfusion injury by inducing cardiomyocyte apoptosis and myocardial inflammation. 
have demonstrated that the ER stress response is activated in rodent models of myocardial I/R. 9 -12 Moreover, overexpression of activating transcription factor-6, an ER stress sensor, induced expression of numerous ER stress response genes without a significant induction of chop, showing protective effects against reperfusion injury. 9 General activation of ER stress response by a prolyl hydroxylase inhibitor resulted in reduced cardiomyocyte apoptosis with decreased expression of chop after reperfusion. 10 In addition, general inhibition of the ER stress response by a ␦-protein kinase C inhibitor or ghrelin also results in reduced injury size or cardiomyocyte apoptosis, respectively. 11, 12 Thus, ER stress appears to regulate myocardial I/R injury variably, attenuating or exacerbating, possibly depending on the balance between prosurvival and CHOP-related proapoptotic ER stress responses, but the direct involvement of CHOP in this pathological process has not yet been demonstrated. In the current study, we investigated whether and how the CHOP-mediated pathway contributes to development of myocardial I/R injury using mice genetically deficient in chop.
Methods

chop-deficient (CHOP
Ϫ/Ϫ ) mice were generated as previously described. 13 Mice were provided by Prof Shizuo Akira (Osaka University, Osaka, Japan), and backcrossed more than 6 times to the C57BL/6J strain. Wild-type C57BL/6J (WT) mice were purchased from CLEA Japan. The experimental protocol was approved by the Animal Research Committee at Kumamoto University, and all procedures conformed to the Guide for the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources. Eight-to 12-week-old male mice underwent 50 minutes of left coronary artery occlusion followed by reperfusion. Injury area (IA), area at risk (AAR), and normally perfused area of left ventricle (LV) were determined by Evans blue/triphenyltetrazolium chloride (TTC) double staining. Injury size and ischemic size was defined as the weight ratios of IA to AAR (IA/AAR) and AAR to LV (AAR/LV), respectively. Neonatal mouse cardiomyocyte culture was prepared as described previously, with modifications. 14 Additional details are provided in the Supplemental Data, available online at http://atvb.ahajournals.org.
Results
Myocardial I/R Activates the CHOP-Mediated Pathway via the ER Stress Response
To determine whether the CHOP-mediated pathway is activated in the ischemic myocardium in response to I/R, we subjected WT mice to left coronary artery occlusion for 50 minutes followed by reperfusion. In the ischemic myocardium, induction of chop mRNA occurred as early as 30 minutes to 2 hours after reperfusion (2.7-fold compared with shamoperated mice), but induction was not seen in the normally perfused myocardium ( Figure 1A ). Because excessive ER stress reportedly activates the CHOP-mediated pathway, [1] [2] [3] we evaluated the alterations in the ER stress response pathways initiated by 3 ER stress sensors: protein kinase RNA-like ER kinase, activating transcription factor-6, and IRE1. Protein kinase RNA-like ER kinase-mediated phosphorylation of ␣-subunit of eukaryotic translation initiation factor-2 was clearly detectable at the same time point as induction of chop mRNA ( Figure 1B , upper panel; Figure  1C ). Activating transcription factor-6 -mediated transcription of xbp1 (levels of total xbp1 mRNA) and subsequent IRE1-dependent splicing of the mRNA (levels of spliced xbp1 [sxbp1] mRNA) 15 showed a biphasic pattern with the first peak at a time point similar to induction of chop mRNA (2 hours) and the second peak at 1 to 3 days ( Figure 1B , lower panel; Figure 1D and 1E). Additionally, immunoblotting analysis for the immunoglobulin-binding protein, a major ER chaperone downstream of sXBP1, showed a biphasic expression pattern with both peaks a little later (4 hours and 3 days, respectively) than those seen for sxbp1 mRNA, as expected ( Figure 1F ). These findings indicate that myocardial I/R activates the CHOP-mediated pathway, probably via the ER stress response.
CHOP Deficiency Attenuates Myocardial Damage After I/R
To determine whether the I/R-activated CHOP-mediated pathway is responsible for development of myocardial I/R injury, we subjected WT and CHOP Ϫ/Ϫ mice to 50 minutes of ischemia followed by 8 hours and 1 day of reperfusion. These time points were selected on the basis of the effect of reperfusion time on injury size in WT mice, increase-to-peak, and subsequent decline-to-plateau phases, respectively (Supplemental Figure I ). At baseline, there were no differences in cardiac morphology and function between mice of either genotype (Supplemental Table I ). TTC staining demonstrated markedly reduced injury size (IA/AAR) in CHOP Ϫ/Ϫ compared with WT mice at 8 hours after reperfusion ( Figure 2A , left panel), and this difference remained significant at 1 day after reperfusion (Figure 2A , right panel), despite comparable ischemic size (AAR/LV) in both mice at either time point. Interestingly, shrinkage of injury size between these time points was observed in both mice, which was more pronounced in WT mice. Transcriptional induction of brain natriuretic peptide (bnp) indicates failing hemodynamics in vivo, because the mRNA is rapidly synthesized in ventricular myocardium in response to LV filling pressures and wall stress. 16 In WT mice, induction of bnp mRNA reached a peak at 8 hours after reperfusion and then gradually decreased (data not shown). However, the 8-hour levels of bnp mRNA in CHOP Ϫ/Ϫ were significantly lower than those in WT mice ( Figure 2B ). These results indicate that the I/R-induced CHOP-mediated pathway causes not only structural but also functional damage to the heart after I/R.
CHOP Deficiency Decreases Cardiomyocyte Apoptosis After I/R
We performed additional experiments to investigate mechanisms underlying the protective effects of CHOP deficiency on myocardial I/R injury. Because CHOP is a key component of the ER stress-induced apoptosis pathway, [1] [2] [3] we examined cardiomyocyte apoptosis after I/R by terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay. Apoptotic cardiomyocytes were defined as TUNEL-positive cells clearly surrounded by sarcomeric actinin. In WT mice, apoptotic cardiomyocytes in the ischemic myocardium were most evident early at 4 hours after reperfusion but then remained at a constant low level up to 8 hours (Supplemental Figure II) . At this early time point, the rate of apoptotic cardiomyocytes was considerably lower in CHOP Ϫ/Ϫ than in WT mice ( Figure 3A and 3B), although the absolute apoptotic rate was low, at most 10%, even in WT mice. CHOP is thought to cause the imbalance of Bcl-2 family members in the mitochondrial outer membrane by upregulation of proapoptotic protein Bax 5 or downregulation of antiapoptotic protein Bcl-2, 17 and it has an important role in mitochondrial release of cytochrome c and subsequent activation of apoptotic caspases. 18, 19 At 4 hours after reperfusion, bax mRNA levels were significantly increased, and bcl-2 mRNA levels tended to be decreased in WT hearts, whereas neither mRNA level was altered in CHOP Ϫ/Ϫ hearts ( Figure 3C ). As a result, the ratio of bcl-2 to bax mRNA levels (Bcl-2/Bax) was significantly reduced in WT but not in CHOP Ϫ/Ϫ mice. These findings suggest that the CHOP-mediated pathway induces cardiomyocyte apoptosis, probably via a mitochondriadependent apoptotic pathway, and that it may contribute to development of I/R injury. However, other mechanisms could also explain the marked difference in injury size seen in WT versus CHOP Ϫ/Ϫ hearts.
CHOP Deficiency Attenuates Inflammatory Response After I/R
Recently, direct involvement of the CHOP-mediated pathway in the inflammatory response has been described in some reports, 20 -22 but not in a model of myocardial injury. Thus, we next evaluated whether CHOP deficiency affects the inflammatory response after myocardial I/R. In WT mice, transcriptional induction of proinflammatory cytokines (tumor necrosis factor [tnf]-␣ and interleukin [il]-1␤) and chemokines for neutrophils and macrophages (macrophage inflammatory protein [mip]-2/cxcl2 and monocyte chemoattractant protein [mcp]-1/ccl2, respectively) in the ischemic myocardium showed a monophasic or biphasic pattern, with the highest peak at 6 to 8 hours after reperfusion, whereas induction of the antiinflammatory cytokine il-10 showed a different monophasic pattern, with a rapid rise peaking at 30 minutes after reperfusion followed by a rapid decline (Supplemental Figure III) . Interestingly, only induction of il-6 reached a peak at 4 hours after reperfusion, a few hours earlier than that of the other proinflammatory cytokines described above. At 8 hours after reperfusion, levels of tnf-␣, il-1␤, il-6, mcp-1, and mip-2 mRNA were all significantly reduced in CHOP Ϫ/Ϫ compared with WT mice, but no differences were observed in il-10 mRNA levels between the genotypes ( Figure 4A ). In agreement with the significant reduction in chemokine levels, subsequent infiltration of inflammatory cells into the ischemic myocardium was significantly inhibited in CHOP Ϫ/Ϫ mice at 1 day after reperfusion (Figure 4B and 4C) . These data indicate that the CHOP-mediated pathway enhances tissue inflammation after I/R, which could constitute another potent mechanism underlying development of myocardial I/R injury.
The CHOP-Mediated Pathway Exhibits Proinflammatory Activity in Response to Inflammatory Stimuli
To confirm the proinflammatory activity of the CHOPmediated pathway, especially in the context of inflammatory conditions, as observed in our myocardial I/R model, we subjected WT and CHOP Ϫ/Ϫ cardiomyocytes to 1 of the following treatments: lipopolysaccharide (LPS) alone, the potent ER stressor thapsigargin (TG) alone, LPS plus TG, or vehicle control. In WT cardiomyocytes, no apparent increase was observed in chop mRNA levels after treatment with LPS alone compared with the vehicle control, whereas a substantial increase was observed after treatment with TG alone or LPS plus TG, both of which stimulated similar increases ( Figure 5A ). This finding indicates that LPS treatment, either alone or together with TG, does not activate the CHOPmediated pathway in our protocol. Under these conditions, induction of tnf-␣ and il-6 mRNA occurred after treatment with LPS alone or LPS plus TG in WT and CHOP Ϫ/Ϫ cardiomyocytes, but induction levels differed significantly between cytokines, as well as genotypes. tnf-␣ mRNA levels after LPS plus TG treatment showed increases similar to those provoked by LPS alone, which were not affected by genotype ( Figure 5B ). In contrast, il-6 mRNA levels after LPS plus TG treatment showed a greater increase than those seen after LPS alone in WT cardiomyocytes, but no further increase was observed in CHOP Ϫ/Ϫ cardiomyocytes ( Figure  5C ). Interestingly, treatment with TG alone did not show any difference in cytokine mRNA levels between cardiomyocytes of either genotype. These results support the proinflammatory property of the CHOP-mediated pathway, which may be enhanced in response to inflammatory stimuli potentially through transcriptional regulation of specific cytokine genes, such as il-6. 
I/R-Induced ROS Generation Triggers the CHOP-Related ER Stress Response
Experimental studies have shown that reperfusion of ischemic myocardium generates a large burst of ROS, which itself serves as a critical mediator in I/R injury. 6, 23, 24 On the other hand, ROS is thought to be a cause of ER stress via several mechanisms, 2, 7, 8, [25] [26] [27] [28] but whether the ROS overproduction after myocardial I/R triggers the CHOP-related ER stress response remains unclear. Thus, we assessed the potential effects of edaravone, a free radical scavenger clinically available in Japan, 29 on regulation of ER stress after myocardial I/R. WT mice were randomly assigned to either the edaravone-or saline-treated group, and subjected to left coronary artery occlusion for 50 minutes followed by reperfusion. Edaravone or saline was administered as an intravenous bolus injection 5 minutes before reperfusion. In the saline-treated group, dihydroethidium staining showed little or no production of intracellular superoxide, a component of ROS, in the ischemic myocardium at the end of 50 minutes of ischemia (data not shown), but it showed evident superoxide production as early as 30 minutes after reperfusion ( Figure  6A ) (the levels of which were similar in both genotypes, as shown in Supplemental Figure IV) . Treatment with 5 mg/kg edaravone almost completely eliminated excess superoxide production and, moreover, inhibited xbp1 splicing ( Figure  6B ) and chop induction ( Figure 6C ). In particular, chop mRNA levels decreased dose dependently with increasing edaravone concentration and were equivalent to shamoperated levels at the highest dose (10 mg/kg). As expected, the edaravone-treated group at a dose of 5 mg/kg, which was nearly equivalent to 10 mg/kg in inhibitory effect on chop induction ( Figure 6C ), exhibited markedly reduced inflammatory response (Supplemental Figure V) and injury size (IA/AAR) compared with the saline-treated group at 8 hours after reperfusion, despite comparable ischemic size (AAR/ LV) in both groups ( Figure 6D ). These data suggest that the ER stress-induced, CHOP-mediated pathway is activated in part by ROS overproduction soon after reperfusion.
Discussion
The transcription factor CHOP is one of the important components directing cell apoptosis in response to severely impaired ER function (ER stress), [1] [2] [3] and its pathological implications are beginning to be recognized from the observations that CHOP deficiency confers resistance to apoptosis in experimental cellular and animal models. 3 In the setting of chronic myocardial ischemia, knockdown of chop resulted in reduced cardiomyocyte apoptosis following exposure to prolonged hypoxia. 30 However, the roles of the CHOP-mediated pathway in the pathological process, especially inflammatory process, of myocardial I/R injury have not been fully elucidated. The current study indicates that in vivo myocardial I/R activates the ER stress-induced, CHOP-mediated pathway partially through ROS overproduction occurring soon after reperfusion and that the pathway subsequently exacerbates myocardial I/R injury not only by inducing cardiomyocyte apoptosis but by enhancing tissue inflammation ( Figure 6E ). Furthermore, in vitro analysis underscores the potential and the complexity of the CHOP-related proinflammatory signaling in inflammatory conditions. This is the first study, to our knowledge, to demonstrate using a myocardial I/R model (not a chronic ischemia model) that reperfusion-dependent ROS production is upstream of ER stress and that CHOP exhibits a proinflammatory activity in the reperfused tissue. Additionally, for the first time, we directly show the time-dependent activation of ER stressors in vivo.
There are numerous reports describing the occurrence of cardiomyocyte apoptosis after myocardial I/R, [31] [32] [33] and some even show the implication of ER stress-induced apoptosis. 9, 10 However, considering that several signaling pathways, such as CHOP-, apoptosis signal-regulating kinase 1-c-Jun N-terminal kinase-, and caspase-12-mediated pathways, could govern ER stress-induced apoptosis, 2, 3 it is of significance for clinical applications to determine the extent to which individual pathways contribute to cardiomyocyte apoptosis after reperfusion. Previous study has shown that either JNK1 or JNK2 deficiency reduces cardiomyocyte apoptosis by approximately 40%. 34 In contrast, our findings have demonstrated that CHOP deficiency almost completely suppressed cardiomyocyte apoptosis in the reperfused myocardium, suggesting that the CHOP-mediated pathway also has a potentially important role in inducing cardiomyocyte apoptosis after I/R. This apoptotic potential may be explained in part by the facts that chop is one of the most highly inducible genes during ER stress 3 and that mitogen-activated protein kinase kinase kinase ASK1, which is required to activate the JNK-mediated pathway during ER stress, can also activate the p38 pathway and subsequently phosphorylate CHOP to enhance its transcriptional activity and elicit a maximal apoptotic effect. 3 To date, several mechanisms have been proposed for CHOP-mediated apoptosis, such as downregulation of the antiapoptotic protein Bcl-2, 17 upregulation of the proapoptotic proteins Bax and Bim, 5, 35 and translocation of Bax to mitochondria, 36 all of which, along with our finding of the Bcl-2/Bax ratio after I/R, support that CHOP-mediated apoptosis occurs mainly through a mitochondria-dependent pathway. 18, 19 However, the precise apoptosis cascade downstream of CHOP is still unclear and requires further investigation.
Recent observations suggest that ER stress response can initiate an inflammatory response through various mechanisms. 1 However, a relationship between the CHOP-mediated pathway and inflammation has not been fully clarified. 20 -22 Our findings suggest that the CHOP-mediated pathway enhances myocardial inflammation, possibly by transcriptional regulation of specific cytokine genes, such as il-6 (but not tnf-␣). This possibility is supported by the study of Li et al, who demonstrated that free cholesterol accumulation in macrophages led to activation of multiple inflammatory signaling pathways, of which the CHOP-extracellular signal regulated kinase 1/2 pathway was specifically implicated in il-6 mRNA increase but not in tnf-␣ upregulation. 20 Consistently, our preliminary immunoblot data using cultured cardiomyocytes suggest that the CHOP-mediated pathway increases extracellular signal regulated kinase 1/2 phosphorylation (data not shown). On the other hand, most recently, a similar synergistic effect on cytokine mRNA induction in response to LPS plus TG treatment was observed for il-23 in a human monocyte cell line, which was strongly inhibited by chop knockdown. 37 This observation would be helpful to further confirm the proinflammatory property of the CHOP-mediated pathway, but the regulatory mechanism is probably different between the 2 cytokines because CHOP binds to the il-23 promoter but not to the il-6 promoter. 38 Other proinflammatory mechanisms have also been proposed. One report using a mouse model of acute pneumonia showed that CHOP Ϫ/Ϫ mice exhibited reduced tissue inflammation and IL-1␤ activity through loss of CHOP-dependent induction of caspase-11, a component of the inflammasome. 21 Another identified the CHOP-binding consensus sequence in the promoter region of CD11b (a component of Mac-1) and showed that macrophage infiltration into colonic tissue was suppressed in CHOP Ϫ/Ϫ mice in a model of inflammatory bowel disease. 22 In agreement with these reports, we found that CHOP Ϫ/Ϫ hearts exhibited lower levels of caspase-11 expression (data not shown) and macrophage infiltration than did WT hearts after reperfusion. These proinflammatory properties of the CHOP-mediated pathway, however, might be observed in the context of inflammatory conditions, given that treatment with TG alone did not show any difference in il-6 levels between WT and CHOP Ϫ/Ϫ cardiomyocytes (these results are similar to those of the recent study for il-23 37 ) and that our study and the 3 reports as described above were all based on data derived from inflammatory models. Nonetheless, the underlying genetic and molecular interaction between the CHOP-mediated pathway and inflammatory signaling pathway is of great interest and needs further investigation.
The ER is thought to be one of the organelles that is highly susceptible to oxidative stress. High calcium concentration within the ER lumen is specifically required for the protein folding ability of ER-resident chaperones, 2 but ROS can release intraluminal calcium, probably by regulation of inositol 1,4,5-triphosphate-operated channels and sarco-ER Catransporting ATPases. 25 Additionally, ROS can directly perturb redox homeostasis within the ER lumen, which specializes in protein folding and disulfide bond formation, 26 and can even cause oxidative damage to ER-resident proteins directly or indirectly through lipid peroxidation. 27, 28 All of these features evoke the idea that ROS induce misfolded protein accumulation and the subsequent ER stress response, but such reports are scarce. Here, in a model of myocardial I/R, we have demonstrated for the first time that excess production of ROS, especially superoxide, after reperfusion has a critical role in activating the ER stress response pathways.
A number of experimental reperfusion therapies have been shown to ameliorate myocardial reperfusion injury, although these beneficial effects have barely been translated into clinical practice. 6, 39 One significant reason for this disparity is thought to be the difficulty of delivering drugs to the right component at the right time and dosage in myocardial I/R. 6, 24 In this regard, edaravone is an excellent free radical scavenger because of several pharmacokinetic advantages, such as intravenous availability, low molecular mass (174.2 kDa), and lipophilicity. Indeed, even in the clinical setting of acute myocardial infarction, edaravone administration immediately before revascularization resulted in smaller enzymatic infarcts and better clinical outcomes, 40 accompanied by lower plasma levels of MCP-1. 41 The current study highlights the protective effects of edaravone on I/R injury by demonstrating its ability to reduce excessive ER stress, in addition to preventing direct oxidative damage. Interestingly, 1 study showed that in mouse glial cells treated with the potent ER stressor tunicamycin, edaravone attenuated xbp1 splicing and translational induction of the immunoglobulin-binding protein and CHOP despite there being no evidence of ROS production, suggesting another potential mechanism for edaravone to reduce ER stress independently of ROS scavenging. 42 In the current study, the injury size shrunk between 8 hours and 1 day after reperfusion, and its extent differed between genotypes. The precise mechanism remains unclear, but given that TTC staining depends on the viability of mitochondrial enzymes (so that enzymatically inactive but living cells, apoptotic cells, or edematous tissue could be included in the area lacking TTC reaction), a possible explanation, based on our mechanistic results, is the clearance of apoptotic cells by neighboring phagocytes or the restoration of vascular permeability, as suggested by mRNA induction of proinflammatory cytokines, reaching a peak at 8 hours and a baseline at up to 1 day (Supplemental Figure III) .
In conclusion, the ER stress-induced, CHOP-mediated pathway has a deleterious effect on the development of myocardial I/R injury. Although care should be taken when extrapolating results from animal studies to human biology, the CHOP-mediated pathway could be a potential target for developing new cardioprotective strategies against myocardial I/R injury.
